Determine the necessary mass, volume, or concentration for preparing a solution.
Ligelizumab (anti-IgE) (Ab175579) - SEC
The purity of Ligelizumab (anti-IgE) (Ab175579) is more than 95% verified by HPLC.
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab175579-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $59.90 | |
Ab175579-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $279.90 | |
Ab175579-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $739.90 | |
Ab175579-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,189.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Ligelizumab (anti-IgE) - Primary antibody, specific to IGHE, >95%, high purity, Human IgG1 |
---|---|
Synonyms | Igh2 antibody; IGHE antibody; IGHEP1 antibody; Immunoglobulin heavy constant epsilon antibody; IgE; immunoglobulin heavy constant epsilon; QGE 031; Anti-IGHE Recombinant Antibody; 利戈组单抗; 利格利珠单抗 |
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Specificity | IGHE |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | INHIBITOR |
Mechanism of action | Antibody of immunoglobulin heavy constant epsilon |
Product Description | Ligelizumab (anti-IgE) is a humanized high-affinity monoclonal anti-IgE antibody. Ligelizumab (anti-IgE) can be used for the research of chronic spontaneous urticarial. |
Isotype | Human IgG1 |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 26.8 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 185.4 kDa, under non-reducing conditions. |
Purification Method | Protein A purified |
Purity | >95% |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 1322627-61-1 |
Ligelizumab (anti-IgE) (Ab175579) - SEC
The purity of Ligelizumab (anti-IgE) (Ab175579) is more than 95% verified by HPLC.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IMGT/mAb-DB | 422 |
---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0405072 | Certificate of Analysis | Apr 30, 2024 | Ab175579 |
ZJ24F0405071 | Certificate of Analysis | Apr 30, 2024 | Ab175579 |
ZJ24F0405070 | Certificate of Analysis | Apr 30, 2024 | Ab175579 |
1. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE et al.. (2011) Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.. Allergy, 66 (3): (317-30). [PMID:21083565] |
2. Arm JP, Bottoli I, Skerjanec A, Floch D, Groenewegen A, Maahs S, Owen CE, Jones I, Lowe PJ. (2014) Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.. Clin Exp Allergy, 44 (11): (1371-85). [PMID:25200415] |
3. Trischler J, Bottoli I, Janocha R, Heusser C, Jaumont X, Lowe P, Gautier A, Pethe A, Woessner R, Zerwes HG et al.. (2021) Ligelizumab treatment for severe asthma: learnings from the clinical development programme.. Clin Transl Immunology, 10 (3): (e1255). [PMID:33747510] |
4. Batista FD, Anand S, Presani G, Efremov DG, Burrone OR. (1996) The two membrane isoforms of human IgE assemble into functionally distinct B cell antigen receptors.. J Exp Med, 184 (6): (2197-205). [PMID:8976175] |
5. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M. (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites.. Nature, 367 (6459): (183-6). [PMID:8114916] |
6. Zhang, K K, Saxon, A A and Max, E E EE.. (1992) Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of epsilon heavy chain membrane exons.. The Journal of experimental medicine, (1): [PMID:1613458] |
7. Pirron, U U, Schlunck, T T, Prinz, J C JC and Rieber, E P EP.. (1990) IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE.. European journal of immunology, [PMID:2167225] |
8. Padlan, E A EA and Davies, D R DR.. (1986) A model of the Fc of immunoglobulin E.. Molecular immunology, [PMID:3796618] |
9. Flanagan, J G JG and Rabbitts, T H TH.. (1982) The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes.. The EMBO journal, [PMID:6234164] |
10. Max, E E EE, Battey, J J, Ney, R R, Kirsch, I R IR and Leder, P P.. (1982) Duplication and deletion in the human immunoglobulin epsilon genes.. Cell, [PMID:6288268] |
11. Seno, M M and 9 more authors.. (1983) Molecular cloning and nucleotide sequencing of human immunoglobulin epsilon chain cDNA.. Nucleic acids research, (11): [PMID:6300763] |
12. Ueda, S S, Nakai, S S, Nishida, Y Y, Hisajima, H H and Honjo, T T.. (1982) Long terminal repeat-like elements flank a human immunoglobulin epsilon pseudogene that lacks introns.. The EMBO journal, [PMID:6327276] |
13. Kenten, J H JH and 6 more authors.. (1982) Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:6815656] |
14. Vouldoukis, I I and 7 more authors.. (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen.. Proceedings of the National Academy of Sciences of the United States of America, (15): [PMID:7544003] |
15. Garman, S C SC, Wurzburg, B A BA, Tarchevskaya, S S SS, Kinet, J P JP and Jardetzky, T S TS.. (2000) Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha.. Nature, (20): [PMID:10917520] |
16. Heilig, Roland R and 98 more authors.. (2003) The DNA sequence and analysis of human chromosome 14.. Nature, (6): [PMID:12508121] |
17. Hibbert, Richard G RG and 9 more authors.. (2005) The structure of human CD23 and its interactions with IgE and CD21.. The Journal of experimental medicine, (19): [PMID:16172256] |
18. Schroeder, Harry W and Cavacini, Lisa.. (2010) Structure and function of immunoglobulins.. The Journal of allergy and clinical immunology, [PMID:20176268] |
19. McHeyzer-Williams, Michael; Okitsu, Shinji; Wang, Nathaniel and McHeyzer-Williams, Louise.. (2011) Molecular programming of B cell memory.. Nature reviews. Immunology, (9): [PMID:22158414] |
20. Joulia, Régis R and 6 more authors.. (2015) Mast cells form antibody-dependent degranulatory synapse for dedicated secretion and defence.. Nature communications, (28): [PMID:25629393] |